Literature DB >> 20015718

Necrotizing fasciitis secondary to bisphosphonate-induced osteonecrosis of the jaw.

Dhave Setabutr1, Nathan W Hales, Greg A Krempl.   

Abstract

Osteonecrosis of the jaw is an uncommon consequence of biphosphonate therapy. This has most commonly been a bone complication with little if any soft tissue involvement. An unusual case of necrotizing fasciitis with extensive soft tissue infection stemming from a prolonged case of osteonecrosis of the jaw presented. The management of this patient (aggressive surgical debridement and prolonged wound care) is reviewed as well as the review of the underlying processes. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20015718     DOI: 10.1016/j.amjoto.2008.11.002

Source DB:  PubMed          Journal:  Am J Otolaryngol        ISSN: 0196-0709            Impact factor:   1.808


  4 in total

1.  Definition and estimation of osteonecrosis of jaw (ONJ), and optimal duration of antiresorptive treatment in bone metastatic cancer patients: supplementary data from the denosumab extension study?

Authors:  Vittorio Fusco; Alberto Bedogni; Alfredo Addeo; Giuseppina Campisi
Journal:  Support Care Cancer       Date:  2016-03-09       Impact factor: 3.603

2.  Hematopoietic progenitor cell transplantation toxicities in multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw: a longitudinal cohort study.

Authors:  Prakash Varadarajan; Juan J Toro; Shuko Lee; Deanna Schneider; Bonita Neumon; Brenda Frye; Robert M Craig; David J Haile; César O Freytes
Journal:  Support Care Cancer       Date:  2012-03-15       Impact factor: 3.603

3.  Osteonecrosis of the Jaw (ONJ) in Osteoporosis Patients: Report of Delayed Diagnosis of a Multisite Case and Commentary about Risks Coming from a Restricted ONJ Definition.

Authors:  Mario Migliario; Giovanni Mergoni; Paolo Vescovi; Iolanda De Martino; Manuela Alessio; Luca Benzi; Filippo Renò; Vittorio Fusco
Journal:  Dent J (Basel)       Date:  2017-03-16

4.  Necrotizing fasciitis secondary to bevacizumab treatment for metastatic rectal adenocarcinoma.

Authors:  Mehmet A N Sendur; Sercan Aksoy; Nuriye Yıldırım Özdemir; Nurullah Zengin
Journal:  Indian J Pharmacol       Date:  2014 Jan-Feb       Impact factor: 1.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.